Jade Therapeutics

Salt Lake City, United States Founded: 2012 • Age: 14 yrs Acquired By EyeGate
Polymer-based products for ophthalmic drug delivery are developed using iontophoresis.
Request Access

About Jade Therapeutics

Jade Therapeutics is a company based in Salt Lake City (United States) founded in 2012 was acquired by EyeGate in March 2016.. Jade Therapeutics operates in a competitive market with competitors including Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.

  • Headquarter Salt Lake City, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Jade Therapeutics, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $725 K (USD), Grant

    Dec 01, 2014

  • Investors
    EyeGate

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    EyeGate

    (Mar 07, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Jade Therapeutics

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $725,000
  • First Round

    (01 Jun 2013)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2014 Amount Grant - Jade Therapeutics Valuation

investors

Jul, 2013 Amount Grant - Jade Therapeutics Valuation

investors

Jun, 2013 Amount Grant - Jade Therapeutics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Jade Therapeutics

Jade Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include EyeGate and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
A government-backed foundation providing seed-stage investments to support small businesses.
Founded Year Domain Location
Therapeutics and drug delivery systems for eye diseases are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Jade Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Jade Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jade Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Jade Therapeutics

Jade Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of therapeutic solutions for the treatment of diabetes
domain founded_year HQ Location
Developer of antibodies to treat complement-mediated neurodegenerative diseases
domain founded_year HQ Location
Drug candidates for immune-mediated diseases are developed by Aldeyra.
domain founded_year HQ Location
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
domain founded_year HQ Location
Mobile SDK developed for app engagement and monetization strategies.
domain founded_year HQ Location
Gene therapies for ocular and neurodegenerative diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Jade Therapeutics

Frequently Asked Questions about Jade Therapeutics

When was Jade Therapeutics founded?

Jade Therapeutics was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Where is Jade Therapeutics located?

Jade Therapeutics is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

What does Jade Therapeutics do?

Jade Therapeutics was founded in 2012 in Salt Lake City, United States, within the biotechnology sector. Locally administered polymer-based systems for treating ophthalmic conditions are developed, with transscleral iontophoresis employed to target drugs in anterior and posterior eye segments. An exclusive worldwide license to BioTime, Inc.s thiolated, cross-linked hyaluronic acid platform for ocular delivery was secured. The company was acquired by EyeGate Pharma in 2016.

Who are the top competitors of Jade Therapeutics?

Jade Therapeutics's top competitors include Annexon, Alimera Sciences and MeiraGTx.

Who are Jade Therapeutics's investors?

Jade Therapeutics has 2 investors. Key investors include EyeGate, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available